Supramolecular nanodevices: from design validation to theranostic nanomedicine.
about
Development of polymeric micelles for targeting intractable cancersBiomedical applications of functionalized hollow mesoporous silica nanoparticles: focusing on molecular imagingActive Tumor Permeation and Uptake of Surface Charge-Switchable Theranostic Nanoparticles for Imaging-Guided Photothermal/Chemo Combinatorial Therapy.Pharmacokinetics, pharmacodynamics and toxicology of theranostic nanoparticlesNanoparticle "switch-on" by tetrazine triggeringColocalized delivery of rapamycin and paclitaxel to tumors enhances synergistic targeting of the PI3K/Akt/mTOR pathway.Fabrication and Characterization of Gd-DTPA-Loaded Chitosan-Poly(Acrylic Acid) Nanoparticles for Magnetic Resonance Imaging.A Theranostic Agent Combining a Two-Photon-Absorbing Photosensitizer for Photodynamic Therapy and a Gadolinium(III) Complex for MRI Detection.Gadolinium Complex of (125)I/(127)I-RGD-DOTA Conjugate as a Tumor-Targeting SPECT/MR Bimodal Imaging Probe.Antibody-powered nucleic acid release using a DNA-based nanomachineFRET-enabled biological characterization of polymeric micelles.Supramolecular disassembly of facially amphiphilic dendrimer assemblies in response to physical, chemical, and biological stimuli.Design of multifunctional magnetic iron oxide nanoparticles/mitoxantrone-loaded liposomes for both magnetic resonance imaging and targeted cancer therapyCo-delivery of doxorubicin and siRNA using octreotide-conjugated gold nanorods for targeted neuroendocrine cancer therapy.Smart nanovehicles based on pH-triggered disassembly of supramolecular peptide-amphiphiles for efficient intracellular drug delivery.Inhibition of cytomegalovirus infection and photothermolysis of infected cells using bioconjugated gold nanoparticlesDNA topology influences molecular machine lifetime in human serumMultifunctional unimolecular micelles for cancer-targeted drug delivery and positron emission tomography imaging.Thailandepsin A-loaded and octreotide-functionalized unimolecular micelles for targeted neuroendocrine cancer therapy.Gold Nanorods Conjugated with Doxorubicin and cRGD for Combined Anticancer Drug Delivery and PET ImagingDoxorubicin Loaded DNA Aptamer Linked Myristilated Chitosan Nanogel for Targeted Drug Delivery to Prostate Cancer.Temperature-sensitive transitions below LCST in amphiphilic dendritic assemblies: host-guest implicationsInfluence of backbone conformational rigidity in temperature-sensitive amphiphilic supramolecular assembliesDual-function theranostic nanoparticles for drug delivery and medical imaging contrast: perspectives and challenges for use in lung diseasesFunctionalized upconversion nanoparticles: versatile nanoplatforms for translational researchCyclodextrin-based supramolecular systems for drug delivery: recent progress and future perspectiveDevelopment of novel tumor-targeted theranostic nanoparticles activated by membrane-type matrix metalloproteinases for combined cancer magnetic resonance imaging and therapySelf-assembly of natural and synthetic drug amphiphiles into discrete supramolecular nanostructures.Aptamer-conjugated and doxorubicin-loaded unimolecular micelles for targeted therapy of prostate cancerBioabsorbable stent quo vadis: a case for nano-theranostics.Gel phase formation in dilute triblock copolyelectrolyte complexes.Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery.Nanomedicine: de novo design of nanodrugs.Enhancing targeted tumor treatment by near IR light-activatable photodynamic-photothermal synergistic therapy.In Vivo Gene-Silencing in Fibrotic Liver by siRNA-Loaded Cationic Nanohydrogel Particles.Endogenous stimuli-sensitive multistage polymeric micelleplex anticancer drug delivery system for efficient tumor penetration and cellular internalization.Smart micelleplexes as a new therapeutic approach for RNA delivery.Antitumor properties of platinum(iv) prodrug-loaded silk fibroin nanoparticles.Development of functional poly(amido amine) CXCR4 antagonists with the ability to mobilize leukocytes and deliver nucleic acids.Cooperative self-assembly of porphyrins with polymers possessing bioactive functions.
P2860
Q26749611-E3DBCAB7-02C4-417A-8EFF-770013837174Q26827998-39A0885C-3883-46D9-B243-FA6F27320277Q27300862-DF78F1B0-0067-413E-9F12-F9E518A4E380Q28084443-0A2E7955-2BC9-4602-8732-6CAB00FABACDQ28822555-057852A2-239E-49BC-B468-795F69EDCD9DQ30583249-468D656D-E5C7-4440-B17D-AC467AA199DEQ30924405-0ADF63A3-64F6-42FD-8A66-92DACCB8632FQ31038537-A4CFEF51-C372-4B7A-BDF9-CED662A63A27Q33636069-B03E97E3-FEDF-465E-84A9-DF5104C1C407Q33654305-59E242CB-AF0D-4CB5-B920-C877E653A40EQ33693454-A7EA4587-B567-445A-9ED7-57BC2E290295Q33910422-E281788E-1C2E-48EE-B99E-9D9317F60329Q34110096-F0B7D5D5-C52C-4279-9C54-C7015CE71F36Q34446374-DBA819D6-0750-4D04-A375-27BD0B8D1003Q35024947-B73BBB1B-9E90-4343-B32B-820ABB348B9EQ35200495-13CDFD1D-5D1F-4878-8498-20862F7342FFQ35688757-F54B3C92-8C8B-4172-95B4-7276886502AFQ35856376-D9401C84-7F45-4D5E-A554-B9E50A20C219Q35963760-4BB55CF6-EEF5-4C3D-8808-5FC6D82A1C28Q36181664-DED73209-3261-4EEF-9786-C22B2D517D5BQ36369789-2CE7512C-E2FD-4D5D-9431-55A454B08BBAQ36996970-C4A15EB4-A31F-40E9-82C2-069B0FF3308AQ37028303-F4E6C652-C1C0-4486-A27A-BD16156B3C5FQ37078082-9D532257-7641-48C9-92B1-1BA1A86FE42BQ37354263-88589E30-9FED-40D5-85DE-030677D98190Q37454370-C1F522C5-91DC-4D6A-96E6-0AF602158527Q37624281-6F1BE0C7-FB33-4DA8-9E9D-A23A1DAD5E77Q37638622-778FF7CA-7914-4DFF-B42A-01D94C0D9D50Q37651650-591A8B48-9546-47C7-BE45-381C1CCBF60EQ37663672-6AA4202B-37D2-41FC-8713-4615ED561310Q37672695-EE56A573-B143-4CC0-B459-DB2A1CB8A600Q38067265-AD8E6EF2-1283-4EF9-A657-B9D1AB0C578AQ38168683-CB433504-8BD5-4C6B-A020-B18945AD8B0AQ38705464-052CD0C6-639B-40AC-9161-A2A8C9461CF2Q38815162-5148FBFE-02B4-4A75-8B07-CD5EA6BC7665Q38837183-CDE20538-E6E4-4670-80EC-5C57B034E410Q38840111-DF0D4539-BF3A-4B86-AC89-71322820C4DDQ38896341-819CA729-5302-4107-98BB-645A4103AA44Q38930550-3254984B-3895-444F-88C3-CE0DB17B1137Q38973285-0356DD6B-725E-4A74-B670-342150C687A6
P2860
Supramolecular nanodevices: from design validation to theranostic nanomedicine.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 July 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Supramolecular nanodevices: from design validation to theranostic nanomedicine.
@en
Supramolecular nanodevices: from design validation to theranostic nanomedicine.
@nl
type
label
Supramolecular nanodevices: from design validation to theranostic nanomedicine.
@en
Supramolecular nanodevices: from design validation to theranostic nanomedicine.
@nl
prefLabel
Supramolecular nanodevices: from design validation to theranostic nanomedicine.
@en
Supramolecular nanodevices: from design validation to theranostic nanomedicine.
@nl
P356
P1476
Supramolecular nanodevices: from design validation to theranostic nanomedicine
@en
P2093
Horacio Cabral
Kazunori Kataoka
P304
P356
10.1021/AR200094A
P407
P577
2011-07-14T00:00:00Z